Animal Health
Biotis works to increase access to innovative, high-quality biological products for animal production industries — supporting healthier animal populations through reliable biological science.
Explore Animal Health
Empowering Science
PT. Biotis Pharmaceuticals Indonesia is built on a shared vision to develop sustainable biotechnology discovering, developing, manufacturing, and commercializing safe, high-quality vaccines.
Who we are
Biotis was brought to life by the shared vision of Pharmtech, Pharmbac, and Harbin Weike Biotechnology to develop sustainable biotechnology. The company is focused on the discovery, development, manufacturing, and commercialization of safe, high-quality vaccines.
We strive to be a benchmark in the vaccine and biotechnology industry. To that end, Biotis has employed advanced technologies across production, quality control, and detection — delivering biotechnology products that meet strict international quality standards.
About BiotisOur business areas
Biotis works to increase access to innovative, high-quality biological products for animal production industries — supporting healthier animal populations through reliable biological science.
Explore Animal Health
Our human health focus is grounded in vaccine development and biotechnology. The company profile documents COVID-19 vaccine production readiness across upstream and downstream processes, formulation, filling, and quality control.
Explore Human HealthScience & innovation
Biotis believes in science that enhances the quality of life. We invest in advanced technologies to deliver high-quality biotechnology products — from cell propagation and purification to formulation and fill-finish.
Quality control and detection are embedded at every stage. Our approach favors transparency: what you see is what you get.
Science & Innovation
What guides us
Integrity is the driving force in all of our processes. We always seek the truth in words as well as actions.
We believe in science that enhances the quality of life. We invest in the most advanced technologies to deliver the highest quality biotechnology products.
We are passionate about our customers, investors, and partners as well as their industries. When we contribute to their excellence, we succeed as well.

Production readiness
The company profile documents COVID-19 vaccine production readiness across upstream processing, harvesting and purification, bulk antigen storage, formulation, vial washing, filling, capping, inspection, labelling, packaging, and storage. Capacity figures are reproduced from the source document and are presented as documented readiness — not as current commercial output.
Manufacturing & Production ReadinessHow Biotis started
Biotis was established from the shared vision of Pharmtech, Pharmbac, and Harbin Weike Biotechnology. Together, they set out to build a biotechnology company focused on the discovery, development, manufacturing, and commercialization of safe, high-quality vaccines — with the ambition of becoming a benchmark in the vaccine industry.
Our story
News & insights
Biotis Pharmaceuticals Indonesia is committed to advancing biotechnology through science, innovation, and a quality-oriented approach to production. Guided by a vision to contribute to global health through the development of modern biotechnology, Biotis seeks to strengthen its capabilities in the vaccine and biotechnology industries.
For partnership, supply, or investment enquiries, our team is ready to respond.
Contact us